Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2017

Apr 4, 2017

34023_dirs_2017-04-04_8c3baf3f-ca2f-4e32-a2b0-018aa8357053.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (agen)
CIK: 0001098972
Period of Report: 2017-03-31

Reporting Person: ARMEN GARO H (Chairman and CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-03-31 Restricted Stock Unit $ A 647000 Acquired 2022-03-31 Common Stock (647000) Direct
2017-03-31 Stock Option, Right to Buy $3.77 A 853000 Acquired 2027-03-31 Common Stock (853000) Direct

Footnotes

F1: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date.

F2: Option vests 100% on 5-year anniversary of the award provided Dr. Armen maintains a service relationship with the Company on such date.